MX9602772A - Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal. - Google Patents
Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal.Info
- Publication number
- MX9602772A MX9602772A MX9602772A MX9602772A MX9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A
- Authority
- MX
- Mexico
- Prior art keywords
- microgranules
- imidazole derivatives
- nitro imidazole
- nitro
- galenic form
- Prior art date
Links
- 150000004958 5-nitroimidazoles Chemical class 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9400394A FR2715067B1 (fr) | 1994-01-14 | 1994-01-14 | Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal. |
| PCT/FR1995/000039 WO1995019168A1 (fr) | 1994-01-14 | 1995-01-12 | Microgranules de derives de 5-nitro imidazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9602772A true MX9602772A (es) | 1997-05-31 |
Family
ID=9459066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9602772A MX9602772A (es) | 1994-01-14 | 1995-01-12 | Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal. |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPH09507499A (cs) |
| KR (1) | KR100320140B1 (cs) |
| CN (1) | CN1088357C (cs) |
| AT (1) | ATE187068T1 (cs) |
| AU (1) | AU705570B2 (cs) |
| BR (1) | BR9506507A (cs) |
| CZ (1) | CZ286080B6 (cs) |
| DE (1) | DE69513632T2 (cs) |
| DK (1) | DK0739201T3 (cs) |
| ES (1) | ES2139883T3 (cs) |
| MA (1) | MA23429A1 (cs) |
| MX (1) | MX9602772A (cs) |
| NZ (1) | NZ279238A (cs) |
| OA (1) | OA10583A (cs) |
| PL (1) | PL178424B1 (cs) |
| PT (1) | PT739201E (cs) |
| RU (1) | RU2152212C1 (cs) |
| SK (1) | SK282066B6 (cs) |
| UA (1) | UA28031C2 (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4331930B2 (ja) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | 酸に不安定な薬物の高含量顆粒 |
| RU2220711C1 (ru) * | 2002-04-24 | 2004-01-10 | Закрытое акционерное общество "Брынцалов-А" | Противомикробное и противопротозойное средство "трихоброл" |
| AU2015311674B2 (en) | 2014-09-05 | 2018-03-08 | Evofem Biosciences, Inc. | Secnidazole for use in the treatment of bacterial vaginosis |
| US12280037B2 (en) | 2020-09-22 | 2025-04-22 | Evofem Biosciences, Inc. | Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346095A (en) * | 1978-02-10 | 1982-08-24 | Mercer James B | Therapeutic treatment for viral hepatitis infection |
| US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
| DE3822095A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Neue arzneimittelformulierung sowie verfahren zu deren herstellung |
| AU7909691A (en) * | 1990-05-14 | 1991-12-10 | Gary R. Jernberg | Surgical implant and method incorporating chemotherapeutic agents |
| FR2692146B1 (fr) * | 1992-06-16 | 1995-06-02 | Ethypharm Sa | Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention. |
-
1995
- 1995-01-12 DK DK95907683T patent/DK0739201T3/da active
- 1995-01-12 SK SK914-96A patent/SK282066B6/sk unknown
- 1995-01-12 PL PL95315530A patent/PL178424B1/pl not_active IP Right Cessation
- 1995-01-12 NZ NZ279238A patent/NZ279238A/en unknown
- 1995-01-12 ES ES95907683T patent/ES2139883T3/es not_active Expired - Lifetime
- 1995-01-12 MX MX9602772A patent/MX9602772A/es not_active IP Right Cessation
- 1995-01-12 RU RU96117257/14A patent/RU2152212C1/ru not_active IP Right Cessation
- 1995-01-12 DE DE69513632T patent/DE69513632T2/de not_active Expired - Fee Related
- 1995-01-12 CN CN95191222A patent/CN1088357C/zh not_active Expired - Fee Related
- 1995-01-12 AU AU15803/95A patent/AU705570B2/en not_active Ceased
- 1995-01-12 PT PT95907683T patent/PT739201E/pt unknown
- 1995-01-12 BR BR9506507A patent/BR9506507A/pt not_active IP Right Cessation
- 1995-01-12 KR KR1019960703797A patent/KR100320140B1/ko not_active Expired - Fee Related
- 1995-01-12 AT AT95907683T patent/ATE187068T1/de not_active IP Right Cessation
- 1995-01-12 JP JP7518878A patent/JPH09507499A/ja active Pending
- 1995-01-12 CZ CZ19962055A patent/CZ286080B6/cs not_active IP Right Cessation
- 1995-01-12 UA UA96083232A patent/UA28031C2/uk unknown
- 1995-01-13 MA MA23756A patent/MA23429A1/fr unknown
-
1996
- 1996-07-12 OA OA60863A patent/OA10583A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK282066B6 (sk) | 2001-10-08 |
| DK0739201T3 (da) | 2000-05-01 |
| BR9506507A (pt) | 1997-09-09 |
| KR100320140B1 (ko) | 2002-07-02 |
| AU1580395A (en) | 1995-08-01 |
| RU2152212C1 (ru) | 2000-07-10 |
| UA28031C2 (uk) | 2000-10-16 |
| CZ286080B6 (cs) | 2000-01-12 |
| PT739201E (pt) | 2000-05-31 |
| CN1088357C (zh) | 2002-07-31 |
| CZ205596A3 (en) | 1996-10-16 |
| OA10583A (en) | 2002-07-10 |
| MA23429A1 (fr) | 1995-10-01 |
| PL315530A1 (en) | 1996-11-12 |
| SK91496A3 (en) | 1996-12-04 |
| AU705570B2 (en) | 1999-05-27 |
| ATE187068T1 (de) | 1999-12-15 |
| NZ279238A (en) | 1998-03-25 |
| DE69513632T2 (de) | 2000-04-06 |
| DE69513632D1 (de) | 2000-01-05 |
| PL178424B1 (pl) | 2000-04-28 |
| CN1138826A (zh) | 1996-12-25 |
| JPH09507499A (ja) | 1997-07-29 |
| ES2139883T3 (es) | 2000-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000007979A3 (en) | Compounds and compositions for delivering active agents | |
| EP0993831A3 (en) | Compounds and compositions for delivering active agents | |
| AU2274201A (en) | Compounds and compositions for delivering active agents | |
| MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
| HUP9601566A3 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
| HUP0001943A3 (en) | Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
| IL110481A0 (en) | 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them | |
| AP1253A (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate. | |
| HUP0203403A3 (en) | New imidazole derivatives, pharmaceutical compositions containing them and their use | |
| IL140710A0 (en) | Pulmonary delivery of active agents | |
| HUP0004225A3 (en) | Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same | |
| HUP0202263A3 (en) | Benzimidazole, indole and imidazo-pyridine derivatives and pharmaceutical compositions containing them | |
| SI0918059T1 (en) | Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| HUP0002324A3 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
| HUP0002952A3 (en) | Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them | |
| AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
| NZ272089A (en) | Quinoline and benzimidazole derivatives; compounds, preparation and pharmaceutical compositions | |
| AU6551198A (en) | Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them | |
| IL127518A (en) | Substituted heterocyclic benzocycloalkenes, their preparation and pharmaceutical compositions having an analgesic effect | |
| MX9602772A (es) | Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal. | |
| HUP0103184A3 (en) | Sulfonyl-biphenyl-methyl-substituted imidazole derivatives, their use and pharmaceutical compositions containing them | |
| AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
| IL104347A0 (en) | Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL127690A0 (en) | Pyridinocyclohexano-1,3- pyrimidine derivatives their preparation their use as medicaments and pharmaceutical formulations including them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |